Cargando…
MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2
Breast cancer is one of the most frequently diagnosed malignancies among women. Triple-negative breast cancer (TNBC) represents a significant challenge for breast oncologists, as the availability of effective therapies for this aggressive disease is limited. The molecular mechanisms underlying TNBC...
Autores principales: | Liu, Heng, Wang, Gangyue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281382/ https://www.ncbi.nlm.nih.gov/pubmed/34306209 http://dx.doi.org/10.3892/etm.2021.10377 |
Ejemplares similares
-
MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD
por: Song, Hongming, et al.
Publicado: (2018) -
MicroRNA-224 Promotes Tumorigenesis through Downregulation of Caspase-9 in Triple-Negative Breast Cancer
por: Zhang, Li, et al.
Publicado: (2019) -
Long noncoding RNA (lncRNA) metallothionein 1 J, pseudogene (MT1JP) is downregulated in triple-negative breast cancer and upregulates microRNA-138 (miR-138) to downregulate hypoxia-inducible factor-1α (HIF-1α)
por: Wang, Gangyue, et al.
Publicado: (2022) -
MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4
por: Xia, Xiang, et al.
Publicado: (2015) -
Curcumol enhances the anti-tumor effects of metformin via suppressing epithelial-mesenchymal transition in triple-negative breast cancer
por: Wang, Gangyue, et al.
Publicado: (2020)